Teclistamab‐Induced Remission of Chronic Immune Thrombocytopenia in a Patient With Multiple Myeloma
eJHaem · 2025-06 · 6 (3)
DOI: 10.1002/jha2.70062 ↗Kurz gefasst
Fachartikel in der Zeitschrift eJHaem, online erschienen am 25.05.2025. Verfasst von Renata Quevedo-Salazar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Tecnologico de Monterrey Internal Medicine, Monterrey Nuevo Leon Mexico. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
We report the case of a 76‐year‐old woman with refractory immune thrombocytopenia (ITP) and multiple myeloma (MM) who achieved remission of both conditions following teclistamab treatment. After failing multiple ITP therapies, her platelet count continued to decline. Initiation of teclistamab led to a rapid and sustained platelet increase, alongside MM response with measurable residual disease (MRD) negativity. Notably, remission was achieved after only four full doses, and the patient has remained in complete remission since. This case highlights teclistamab as a potential treatment for refractory ITP, suggesting a novel role for B‐cell maturation antigen (BCMA)‐targeted therapies in autoimmune diseases. Trial Registration The authors have confirmed clinical trial registration is not needed for this submission.
Autor:innen und Institutionen
- Tecnologico de Monterrey Internal Medicine, Monterrey Nuevo Leon Mexico.
- Clinica Gomez Almaguer, Hematology Monterrey Nuevo Leon Mexico.
- Hospital Universitario Dr. Jose Eleuterio Gonzalez Universidad Autonoma de Nuevo Leon, Hematology Monterrey Nuevo Leon Mexico.
ORCID-Profile: Renata Quevedo-Salazar, José Miguel Yáñez-Reyes, Elías Eugenio González-López, Ana Varela-Constantino, Andrés Gómez-De León, Xitlaly Judith González-Leal, David Gómez-Almaguer
Zitieren
APA
Quevedo-Salazar, R., Yáñez-Reyes, J. M., González-López, E. E., Varela-Constantino, A., Gómez-De León, A., González-Leal, X. J., & Gómez-Almaguer, D. (2025). Teclistamab‐Induced Remission of Chronic Immune Thrombocytopenia in a Patient With Multiple Myeloma. eJHaem, 6(3). https://doi.org/10.1002/jha2.70062
Vancouver
Quevedo-Salazar R, Yáñez-Reyes JM, González-López EE, Varela-Constantino A, Gómez-De León A, González-Leal XJ, et al. Teclistamab‐Induced Remission of Chronic Immune Thrombocytopenia in a Patient With Multiple Myeloma. eJHaem. 2025;6(3). doi:10.1002/jha2.70062
BibTeX
@article{QuevedoSalazar2025,
author = {Quevedo-Salazar, Renata and Yáñez-Reyes, José Miguel and González-López, Elías Eugenio and Varela-Constantino, Ana and Gómez-De León, Andrés and González-Leal, Xitlaly Judith and Gómez-Almaguer, David},
title = {Teclistamab‐Induced Remission of Chronic Immune Thrombocytopenia in a Patient With Multiple Myeloma},
journal = {eJHaem},
year = {2025},
volume = {6},
number = {3},
doi = {10.1002/jha2.70062}
}
EUVIMED